Close Menu

NEW YORK (GenomeWeb) – Phenomix Sciences — an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases — announced today that it is launching a $1 million seed financing round through a crowdfunding platform.

The privately held firm said it intends to use the financing to commercialize a new clinical test for obesity. The diagnostic uses technology developed by the Mayo Clinic to analyze metabolomic and DNA biomarkers to characterize obesity and guide more effective weight loss treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.